AMAline Castello Branco Mancuso

Aline Castello Branco Mancuso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aline Castello Branco Mancuso has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PSS Health: como calcular tamanho de amostra para testar hipóteses de variáveis quantitativas

    by Aline Castello Branco Mancuso, Stela Maris de Jezus Castro, Vanessa Bielefeldt Leotti, Vânia Naomi Hirakata, Gustavo Thomas, Rogério Boff Borges

    Dando continuidade à série de artigos que pretendem orientar o usuário na utilização da ferramenta PSS Health para o planejamento de uma pesquisa, esta edição apresenta um passo a passo de como realizar o cálculo amostral para testar relações estatísticas entre variáveis e um desfecho quantitativo. Neste artigo, serão abordadas técnicas para: teste de correlação, regressão linear e regressão de Cox. Todos os exemplos também são ilustrados e disponibilizados em vídeo-aulas no canal da Unidade de Bioestatística no YouTube.

  • Open Access

    Analysis of the interval between submission and publication in genetics journals

    by Rafael Leal Zimmer, Aline Castello Branco Mancuso, Ursula Matte, Patricia Ashton-Prolla

    One of the main factors that attracts authors to choose a journal is the time interval between submission and publication, which varies between journals and subject matter. Here, we evaluated the time intervals between submission and publication according to journal impact factor and continent of author’s affiliation, considering articles with authors from single or multiple continents. Altogether, 72 journals indexed in the Web of Science database within the subject matter “Genetics and Heredity”, divided by impact factor into four quartiles and randomly selected were analyzed for time intervals from article submission to publication. Data from a total of 46,349 articles published from 2016 to 2020 were collected and analyzed considering the following time intervals: submission to acceptance (SA), acceptance to publication (AP) and submission to publication (SP). The median of the quartiles for the SP interval was 166 (IQR [118–225]) days for Q1, 147 (IQR [103–206]) days for Q2, 161 (IQR [116–226]) days for Q3 and 137 (IQR [69–264]) days for Q4, showing a significant difference among quartiles (p < 0.001). In Q4, median interval of time was shorter in interval SA but longer in interval AP, and overall, articles in Q4 had the shortest interval of time in SP. A potential association of the median time interval and authors’ continent was analysed and no significant difference was observed between articles with authors from single versus multiple continents or between continents in articles with authors from only one continent. However, in journals from Q4, time from submission to publication was longer for articles with authors from North America and Europe than from other continents, although the difference was not significant. Finally, articles of authors from the African continent had the smallest representation in journals from Q1-Q3 and articles from Oceania were underrepresented in group Q4. The study provides a global analysis of the total time required for submission, acceptance and publication in journals in the field of genetics and heredity. Our results may contribute in the development of strategies to expedite the process of scientific publishing in the field, and to promote equity in knowledge production and dissemination for researchers from all continents.


  • Open Access

    Sales of “COVID kit” drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency

    by Marina Hentschke-Lopes, Mariana R. Botton, Pâmella Borges, Martiela Freitas, Aline Castello Branco Mancuso, Ursula Matte

    Off-label use of azithromycin, hydroxychloroquine, and ivermectin (the “COVID kit”) has been suggested for COVID-19 treatment in Brazil without clinical or scientific evidence of efficacy. These drugs have known adverse drug reactions (ADR). This study aimed to analyze if the sales of drugs in the “COVID kit” are correlated to the reported number of ADR after the COVID-19 pandemic began. Data was obtained from the Brazilian Health Regulatory Agency (Anvisa) website on reported sales and ADRs for azithromycin, hydroxychloroquine, and ivermectin for all Brazilian states. The period from March 2019 to February 2020 (before the pandemic) was compared to that from March 2020 to February 2021 (during the pandemic). Trend adjustment was performed for time series data and cross-correlation analysis to investigate correlation between sales and ADR within the same month (lag 0) and in the following months (lag 1 and lag 2). Spearman’s correlation coefficient was used to assess the magnitude of the correlations. After the pandemic onset, sales of all investigated drugs increased significantly (69.75% for azithromycin, 10,856,481.39% for hydroxychloroquine, and 12,291,129.32% for ivermectin). ADR levels of all medications but azithromycin were zero before the pandemic, but increased after its onset. Cross-correlation analysis was significant in lag 1 for all drugs nationwide. Spearman’s correlation was moderate for azithromycin and hydroxychloroquine but absent for ivermectin. Data must be interpreted cautiously since no active search for ADR was performed. Our results show that the increased and indiscriminate use of ”COVID kit“ during the pandemic correlates to an increased occurrence of ADRs.


  • PSS.Health: Power and Sample Size for Health Researchers via Shiny

    by Rogério Boff Borges, Guilherme Serpa Azambuja, Aline Castello Branco Mancuso, Vanessa Bielefeldt Leotti, Vânia Naomi Hirakata, Suzi Alves Camey, Stela Maris de Jezus Castro, Gustavo Thomas


  • Open Access

    A comparative study on combinations of forecasts and their individual forecasts by means of simulated series

    by Aline Castello Branco Mancuso, Liane Werner

    Over the years, several studies that compare individual forecasts with the combination of forecasts were published. There is, however, no unanimity in the conclusions. Furthermore, methods of combination by regression are poorly explored. This paper presents a comparative study of three methods of combination and their individual forecasts. Based on simulated data, it is evaluated the accuracy of Artificial Neural Networks, ARIMA and exponential smoothing models; calculating the combined forecasts through simple average, minimum variance and regression methods. Four accuracy measurements, MAE, MAPE, RMSE and Theil’s U, were used for choosing the most accurate method. The main contribution is the accuracy of the combination by regression methods.